Hear this! Potential therapeutics for COVID-19 should be tested for auditory safety.

As the COVID-19 pandemic continues to spread across the world, clinicians, academic institutions, private organizations, and governments are working tirelessly to find treatments to help patients and at-risk populations threatened by this novel disease.

China shows off Covid-19 vaccines for first time.

China has put its homegrown coronavirus vaccines on display for the first time, as the country where the contagion was discovered looks to shape the narrative surrounding the pandemic.

Oxford University vaccine trial paused after participant falls ill.

Final clinical trials for a coronavirus vaccine, developed by AstraZeneca and Oxford University, have been put on hold after a participant had a suspected adverse reaction in the UK...

Ohio State University researchers working on promising COVID-19 vaccine.

An experimental vaccine under research at The Ohio State University has shown the potential to be an option moving forward in the quest to stamp out COVID-19.

Mesoblast Limited receives ethics approval to treat COVID-19 patients in Australia.

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, announced that it has received ethics approval to include Australian hospitals in thePhase 3 randomized controlled trial...

Merck announces positive results phase 3 trials of gefapixant 45 mg twice daily in patients with refractory or unexplained chronic cough.

Merck, known as MSD outside the United States and Canada, has announced the results from two pivotal phase 3 trials evaluating the efficacy and safety...

Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate.

Sanofi and GSK started the Phase 1/2 clinical trial for their adjuvanted COVID-19 vaccine. The vaccine candidate, developed in partnership by Sanofi...

Sinovac Biotech's COVID-19 vaccine enters phase 3 trial globally.

A COVID-19 vaccine candidate developed by Beijing-based Sinovac Life Sciences Corp has obtained preliminary approval in Bangladesh for entering phase III clinical trials, the company.

Phesi data show clinical trial suspensions continue to rise as COVID-19 impact on development persists.

Analysis from Phesi shows the impact of COVID-19 on clinical development is continuing to mount, with many clinical trial sites unable to bounce back following suspension in March and April 2020.

Delivery of COVID-19 vaccine: DHL study shows how public and private sector can partner for success.

With first emergency use authorizations for COVID-19 vaccines expected to be effective in the last quarter of 2020, logistics providers are challenged to rapidly establish medical supply chains...

FedEx Logistics Opens Foreign Trade Zone in El Paso, Texas.

FedEx Logistics announced the opening of another Foreign Trade Zone location in El Paso, Texas, U.S. The site in El Paso is the latest FTZ facility to be opened by FedEx Logistics to existing...